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        Introduction 
  EGF family members are synthesized as type I transmembrane 
proteins. A member of the family, heparin-binding EGF-like 
growth factor (HB-EGF), which is a potent mitogen and chemo-
tactic factor for various types of cells, expresses on the plasma 
membrane as a 20  –  30-kD precursor (proHB-EGF) containing 
an extracellular EGF-like domain, a transmembrane segment, and 
a short cytoplasmic tail (  Higashiyama et al., 1991  ). The proHB-
EGF is cleaved at the juxtamembrane domain via metalloprotease 
activation, yielding a soluble EGF receptor ligand and a C-terminal 
fragment containing transmembrane and cytoplasmic segments 
(HB-EGF-CTF). This process, called ectodomain shedding, can 
be stimulated by various physiological and pharmacological 
agonists, including 12-  O -tetradecanoylphorbol-13-acetate  (TPA) 
(  Goishi et al., 1995  ), calcium ionophores (  Dethlefsen et al., 1998 ), 
G protein  –  coupled receptor ligands (  Prenzel et al., 1999  ), and 
cytokines and growth factors (  Tanida et al., 2004  ;   Nanba et al., 
2008  ). Although the EGF-like domain alone is suffi  cient to elicit 
EGF receptor phosphorylation, recent studies have shown some 
biological activities for the conserved cytoplasmic tail of proHB-
EGF (HB-EGF-cyto), which contains 24 amino acids. For instance, 
the multi-functional protein BAG-1 binds to HB-EGF-cyto and 
increases HB-EGF secretion (  Lin et al., 2001  ). A serine residue in 
HB-EGF-cyto is phosphorylated in response to shedding stimuli 
(  Wang et al., 2006  ). Our group has found that HB-EGF-cyto 
  interacts with transcriptional repressors, promyelocytic leukemia 
zinc fi  nger protein (PLZF) and B cell lymphoma 6 (Bcl6), re-
sulting in the reversal of PLZF- and Bcl6-mediated gene repression 
(  Nanba et al., 2003  ;   Kinugasa et al., 2007  ). These data suggest that 
HB-EGF-cyto is able to function in the nucleus, thus raising an 
intriguing question: how is HB-EGF-cyto targeted to the nucleus? 
  The nuclear envelope (NE) consists of an inner nuclear 
membrane (INM) and an outer nuclear membrane (ONM), which 
are joined at the nuclear pore membrane. The ONM is structurally 
continuous with the peripheral ER. One model explaining the 
targeting of integral protein from the ER to the INM is that reloca-
tion is accomplished by passive diffusion in the interconnected 
ER, ONM, pore, and INM. The proteins are then tethered to the 
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INM as a result of interactions with the INM resident proteins 
(for review see   Holmer and Worman 2001  ). In other models, the 
traffi  cking of some integral membrane proteins to the INM re-
quires energy (  Ohba et al., 2004  ) and is mediated by multiple 
protein interactions (  King et al., 2006  ;   Saksena et al., 2006  ; 
  Braunagel et al., 2007  ). This study shows that ectodomain-
shedding stimuli trigger the translocation of membrane-anchored 
HB-EGF to the INM via a retrograde transmembrane traffi  cking 
pathway, where it can bind to transcriptional repressors. 
  Results and discussion 
  TPA treatment induces relocalization of 
HB-EGF-cyto to the NE 
  Although HB-EGF-cyto interacts with transcriptional repres-
sors to suppress their repressive activity (  Nanba et al., 2003  ; 
  Kinugasa et al., 2007  ), detailed analysis on the nature of HB-
EGF-cyto has been hampered partly because of a lack of available 
specifi  c antibodies. Thus, we raised mAbs against a synthetic 
peptide corresponding to HB-EGF-cyto and obtained one clone, 
designated mAbD, which specifi  cally reacted with proHB-EGF 
and HB-EGF-CTF (  Fig. 1 B  ). The mAbD reactivity was abro-
gated by deleting the C-terminal 10 amino acids (199  –  208) of 
HB-EGF. mAbD recognized the 15-mer peptide (194  –  208), but 
not the 10-mer peptide (199  –  208). Thus, the epitope was mapped 
in the 194  –  208 region (  Fig. 1, B and C  ). We then performed 
immunofl  uorescence microscopy in cells expressing proHB-EGF. 
In the absence of ectodomain-shedding stimuli, or TPA, the 
mAbD gave signals predominantly on the plasma membrane in 
most of the cells examined and also in the perinuclear regions of 
some cells (  Fig. 1 D  ). The perinuclear signal probably repre-
sents newly synthesized (pre)proHB-EGF because it colocalized 
with the Golgi apparatus marker,    1,4-galactosyltransferase, 
and disappeared after translation block by cycloheximide (un-
published data). After TPA treatment, mAbD staining almost 
completely disappeared from the plasma membrane and was 
found in the NE and reticular network. The NE signal obviously 
overlapped with lamin B, which resides at the nucleoplasmic 
face of the INM (  Fig. 1 D  ), and the reticular network also was 
co-stained with the ER marker (unpublished data). These fi  nd-
ings raised the possibility that after the ectodomain shedding on 
the plasma membrane, the membrane-anchored HB-EGF-cyto 
(maHB-EGF-cyto), which indicates both proHB-EGF and 
HB-EGF-CTF, translocated to the ER/NE. Notably, when anti-
HB-EGF polyclonal antibodies (#H6), which recognize the 
extracellular EGF-like domain (  Miyagawa et al., 1995  ), were used, 
essentially the same staining pattern as mAbD was observed 
(  Fig. 1 E  ). Uncleavable HB-EGF mutant (L148G) was then 
  Figure 1.       Membrane-anchored HB-EGF is targeted to the NE.   (A) Schematic 
presentation of HB-EGF. The proHB-EGF is cleaved at the juxtamembrane 
domain, resulting in production of soluble HB-EGF and HB-EGF-CTF. mAbD 
spe  ciﬁ   cally recognizes HB-EGF-cyto, and #H6 recognizes the extracellular 
domain of proHB-EGF (amino acids 54  –  73). The underline shows the epitope 
region. TM, transmembrane domain; Cyto, HB-EGF-cyto. (B) Total cell lysates 
expressing YFP-tagged wild-type or C-terminal 10 amino acids-deleted HB-EGF 
(    10C) were analyzed by immunoblotting with mAbD (left) or anti-GFP 
antibodies (right). *, proHB-EGF-YFP; **, HB-EGF-CTF-YFP; ***, YFP; arrows, 
degradation products. (C) Total cell lysate expressing GFP-fused C-terminal 
10- or 15-amino acid regions of HB-EGF were probed with mAbD (left) 
or anti-GFP antibodies (right). (D and E) HT1080 cells transfected with 
HB-EGF were treated with TPA and double-stained with mAbD and anti-
lamin B or mAbD and #H6 antibodies. (F) Uncleavable form of HB-EGF 
expressing cells were stained with mAbD.     
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used to test the ectodomain-shedding requirement. As a result, 
the mutant HB-EGF was internalized into the cytoplasm but not 
targeted to the NE (  Fig. 1 F  ). In the cells stably expressing me-
talloproteinase domain lacking ADAM12, the ectodomain shed-
ding of proHB-EGF was disturbed (  Asakura et al., 2002  ) and the 
NE localization of HB-EGF-cyto was suppressed (unpublished 
data). Therefore, some ectodomain shedding is essential for the 
translocation of maHB-EGF-cyto into the NE and may trigger 
the activation of a retrograde sorting signal in HB-EGF-cyto. 
  maHB-EGF-cyto is targeted to the INM 
  To further analyze the NE translocation of maHB-EGF-cyto, 
another antibody was used. A V5-epitope tag was inserted just 
downstream from the transmembrane domains (termed HB-
EGF-V5-C) because tagging at the C terminus interferes with 
the HB-EGF-cyto function (  Nanba et al., 2003  ) and stabilizes 
phosphorylation in HB-EGF-cyto (  Wang et al., 2006  ). The shed-
ding of HB-EGF-V5-C was confi  rmed by Western blotting, and 
its effi  ciency was slightly lower than wild type (unpublished data). 
In the absence of shedding stimuli, the expression pattern of 
HB-EGF-V5-C in the plasma membrane and perinuclear area 
was essentially the same as that observed for wild type. Upon TPA 
stimulation, plasma membrane staining was decreased, and a 
strong signal at the NE and the reticular network was again 
observed and quantitated with statistical signifi  cance (  Fig. 2 A;   
  Fig. S1,   available at http://www.jcb.org/cgi/content/full/jcb
.200710022/DC1). Because it is well known that various cyto-
kines and growth factors induce the ectodomain shedding of 
proHB-EGF, we further used more physiological ligands, such 
as bFGF and EGF. As shown in   Fig. 2 B  , both bFGF and EGF 
induced the V5-signal translocation to the NE, whereas effi  ciency 
was lower than with TPA. 
  If maHB-EGF-cyto is targeted to the INM, cytoplasmic 
domains face the nucleoplasm and physically interact with pro-
teins localized inside the nucleus. Therefore, it is essential to 
elucidate whether maHB-EGF-cyto localizes at the INM or ONM, 
so the following experiments were performed. First, since mem-
brane proteins known to be targeted to INM resist Triton X-100 
extraction (  Gerace et al., 1982  ;   Furukawa et al., 1995  ) because 
of tight interactions with nuclear structures (e.g., nuclear lamina 
or chromatin), maHB-EGF-cyto was tested to share this character. 
In non-TPA  –  treated cells, the HB-EGF-V5-C was readily ex-
tracted with Triton X-100. In contrast, in TPA-treated cells the 
HB-EGF-V5-C remained at the NE, while the signal at the reticu-
lar network was decreased by Triton X-100 extraction (  Fig. 2 C  ). 
EGF or bFGF also induced the detergent-resistant NE localization 
(Fig. S1 C). Consequently, maHB-EGF-cyto becomes detergent-
unextractable after translocation to the NE, suggesting that 
maHB-EGF-cyto could be at the INM. Second, an experiment 
was designed to take advantage of the fact that low concentra-
tions of digitonin selectively permeabilize plasma membranes, 
  Figure 2.       HB-EGF is targeted to the INM.   HB-EGF-V5-C was transiently 
transfected into the cells. (A and B) Cells were treated with either TPA, 
bFGF, or EGF, then stained with an anti-V5 mAb. (C) Cells were treated 
with TPA and extracted with Triton X-100, then ﬁ  xed and stained with either 
anti-V5 mAb or #H6. (D) Cells were permeabilized with digitonin and ﬁ  xed. 
The cells were incubated with (bottom) or without (top) Triton X-100 and 
labeled with mAbD and anti-lamin B antibodies. Bar, 10     m. (E) Ultra-thin 
sections were stained with anti-V5 and 15-nm gold  –  conjugated second 
antibodies. PM; plasma membrane. Bar, 200 nm.     
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  Figure 3.       HB-EGF-cyto has the ability to target to the NE.   (A and D) Sche-
matic presentation of the constructs. (B, E, and G) Indicated constructs 
were transfected and visualized with GFP. (C and F) Indicated constructs 
at the left-hand side were transfected and visualized with GFP and anti-
lamin B antibodies. Though HB-EGF-cyto in LAP2     fusion protein has ﬂ  ipped 
orientation as compared with the native protein, it does not interfere with 
NE targeting. Bar, 10     m.     
while leaving nuclear membranes intact (  Adam et al., 1990  ). 
Cells expressing HB-EGF-V5-C were permeabilized with digi-
tonin, then fi  xed and labeled with anti-lamin B and mAbD anti-
bodies. Lamin B and NE-targeted HB-EGF-V5-C signals were 
not detected (  Fig. 2 D  , top). After Triton X-100 permeabilization, 
the HB-EGF-V5-C signal in the NE was detected only in TPA-
treated cells, whereas the lamin B signal was detected in both 
cells regardless of TPA treatment (  Fig. 2 D  , bottom). This result 
indicates that in TPA-treated cells HB-EGF-cyto is inside the 
nucleus, which required Triton X-100 permeabilization for anti-
body access, suggesting that maHB-EGF-cyto is localized at 
the INM. Next, immunoelectron microscopy showed compelling 
evidence that the HB-EGF-cyto signal was detected at the 
nucleoplasmic face of the NE in TPA-treated cells (  Fig. 2 E  ). 
Collectively, we concluded that maHB-EGF-cyto can be local-
ized at the INM upon shedding stimuli. 
  HB-EGF-cyto has the ability to localize 
to the NE 
  The transmembrane domain of lamina-associated polypeptide 2    
(LAP2    ), which is an integral INM protein, was used to identify 
the crucial amino acids in HB-EGF-cyto for NE localization. 
A C-terminal fragment of LAP2     (410 – 452,  LAP2bTM)  is 
responsible for membrane insertion, and a large hydrophilic 
domain (1  –  409) promotes localization at the INM. Consistent with 
previous data (  Furukawa et al., 1995  ), GFP-tagged LAP2   TM 
(GFP-LAP2    TM) was distributed throughout the membrane 
structure in the cytoplasm. In contrast, insertion of HB-EGF-
cyto into the GFP-Lap2    TM changed its localization in the 
reticular meshwork and the NE (  Fig. 3, B and C  ), indicating that 
HB-EGF-cyto has the ability to allow the membrane protein to 
localize to the NE. Next, three fragments of HB-EGF-cyto were 
inserted into the GFP-LAP2  TM ( Fig. 3 D ). The GFP-LAP2  TM 
containing HB-EGF-cyto 185 – 198 and 185 – 203, but not 199 –  208, 
were localized at the NE and the reticular meshwork (  Fig. 3, 
E and F  ), indicating that the 185  –  198 amino acid region is suffi  -
cient for NE localization. It should be noted that the NE-targeting 
activity of HB-EGF-cyto is constitutively active when it is fused 
to LAP2    TM; nevertheless, its activity is masked when proHB-
EGF is newly synthesized on ER. 
  It was recently reported that some integral INM proteins 
possess a basic sequence motif that resembles classical NLS and 
binds to karyopherin-     (  King et al., 2006  ). However, interactions 
between HB-EGF-cyto and three importin      subtypes (human 
karyopherin-    ) were not detected (unpublished data). Furthermore, 
GFP-fused cytoplasmic tail of HB-EGF was distributed through-
out the cell, including the cytoplasm and nucleoplasm, as was GFP 
(  Fig. 3 G  ). This indicates that HB-EGF-cyto has no detectable 
NLS activity for a soluble protein and that the transmembrane 
region is indispensable for NE targeting. Because HB-EGF-cyto 
delivers a membrane protein to the NE, it is feasible that both 
proHB-EGF and HB-EGF-CTF can be targeted to the NE. 
  K201 in HB-EGF-cyto is essential for the 
NE targeting 
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with multiple sorting determinants. Based on our results, a 
model for this retrograde pathway is proposed in   Fig. 5  . An in-
tegral membrane protein, pro-HB-EGF, is primarily localized at 
the plasma membrane with a dynamic equilibration between 
endocytic and recycling membrane traffi  cking pathways. In re-
sponse to shedding stimuli, endocytosed maHB-EGF-cyto can-
not be recycled back to the plasma membrane, possibly due to 
the stimulation-dependent phosphorylation on Ser207, following 
  Figure 4.       NE targeting of HB-EGF-cyto  –  containing fragments use the 
retrograde membrane trafﬁ  c pathway.   (A) Comparison of the cytoplas-
mic domain of proHB-EGF. (B and C) Schematic presentation of mutated 
proHB-EGF. Indicated constructs were transfected and visualized with anti-
V5 mAb. (D) HB-EGF-V5-C was coexpressed with dominant-active Rab5 or 
Rab11. After TPA treatment, the cells were visualized with anti-V5 mAb.     
 activity of HB-EGF-cyto must be inactivated. ER-resident integral 
membrane proteins are continuously exported by vesicular traf-
fi  cking and recycled back from the Golgi apparatus. The re-
trieval of type I integral membrane proteins from the Golgi 
apparatus is directed by cytoplasmic K(X)KXX motifs located 
at the C terminus (for review see   Duden, 2003  ). Interestingly, a 
conserved KXKXX ER retrieval signal-like sequence was iden-
tifi  ed in HB-EGF-cyto, although it was not exposed at the distal 
terminus (  Fig. 4 A  ). The deletion of fi  ve amino acids from 
proHB-EGF (HB-EGF-V5-    C), exposing   199 KVKLG 203   at  the 
C terminus, resulted in its localization to the ER even without 
TPA treatment. The deleted 5-amino acid region is not essential 
for plasma membrane localization because K201A point-mutated 
HB-EGF-V5-   C  (HB-EGF-V5-m   C) localized at the plasma 
membrane (  Fig. 4 B  ). In Western blotting analysis, the molecu-
lar size of proHB-EGF-V5-  C was not altered by TPA treatment; 
that is, HB-EGF-V5-    C accumulated in the ER without ecto-
domain shedding (unpublished data). These data indicate that 
  199 KVKLG 203   is able to function as an ER retrieval signal when 
it is exposed at the distal C terminus. More importantly, point-
mutated proHB-EGF at K201A (HB-EGF-V5-mC) was not 
targeted to the NE, even after TPA treatment (  Fig. 4 C  ). Thus, 
K201 is essential for NE targeting. Some protein toxins (e.g., 
  Pseudomonas   exotoxin) are cleaved at the C terminus before 
activation of the ER retrieval signal (for review see   Sandvig and 
van Deurs, 2002  ). A possible mechanism for activation of the ER 
retrieval signal of HB-EGF-cyto is that some level of ectodomain 
shedding may eventually induce proteolytic processing at the C ter-
minus, thereby activating the ER retrieval signal, although pro-
teolytically processed HB-EGF-cyto was not detected at this 
point by Western blotting analysis (unpublished data). Another 
conceivable mechanism is that protein modifi  cation(s) in HB-
EGF-cyto after exposure to ectodomain-shedding stimuli may 
regulate the activation of retrograde transport; e.g., S207 reportedly 
is phosphorylated upon shedding stimulation (  Wang et al., 2006  ). 
  The NE targeting of maHB-EGF-cyto 
utilizes membrane trafﬁ  cking pathways 
  The involvement of Rab5 and Rab11, key regulators of the 
endocytic membrane traffi  cking pathway, were examined to fur-
ther delineate the transport pathway of the maHB-EGF-cyto from 
the plasma membrane to the NE. Rab5 regulates membrane 
traffi  cking through early endosomes, and Rab11 functions in 
the endocytic recycling pathway via recycling endosomes (for 
review see  Mellman, 1996 ;  Maxfi  eld and McGraw, 2004 ). When 
HB-EGF-V5-C was coexpressed with either a dominant-active 
form of Rab5 or Rab11, the TPA-induced ER/NE accumulation 
of HB-EGF-V5-C was obviously suppressed (  Fig. 4 E  ). How-
ever, these Rab proteins, even when overexpressed, did not affect 
the nuclear transport of soluble proteins containing classical 
NLS (unpublished data). This suggests that the NE targeting of 
maHB-EGF-cyto utilizes Rab5- and Rab11-dependent retrograde 
membrane traffi  cking pathways  —  possibly from the plasma mem-
brane, through early endosomes, followed by recycling endosomes 
to the Golgi apparatus/the ER. 
  The NE targeting of maHB-EGF-cyto from the plasma 
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INM via the nuclear pore complex because the cytoplasmic 
domain is small enough to pass through the nuclear pore complex. 
Alternatively, it can be transported from ONM to INM via 
active transport requiring protein interactions. At the INM, the 
HB-EGF-cyto faces the nucleoplasm and is expected to interact 
with transcriptional repressors such as Bcl6 and PLZF. It has 
been reported that a number of plasma membrane integral 
receptors accumulate in the nucleoplasm  —  the nuclear space 
unassociated with the NE  —  in some physiological situations. 
The cytoplasmic tails in some receptors are cleaved and can 
then migrate as soluble peptides into the nucleus (e.g., ErbB4, 
FGF receptor, and Notch; reviewed in   Bryant and Stow, 2005  ). 
The other receptors (e.g., the EGF receptor) may have to escape 
from the membrane; however, the mechanisms are mostly un-
known. Here, we fi  rst show that a membrane-anchored growth 
factor on the cell surface is targeted to the INM as an integral mem-
brane protein where it could bind to transcriptional repressors. 
The transmembrane-free HB-EGF-cyto has never been de-
tected and maHB-EGF-cyto is a major product after shedding 
stimuli in Western blotting (  Nanba et al., 2003  ). Thus, it is feasible 
that the NE-accumulated maHB-EGF-cyto is responsible for gene 
activation. Recent studies show that proteins of the NE partici-
pate in the regulation of gene transcription on several levels (for 
review see   Akhtar and Gasser, 2007  ;   Brown and Silver, 2007  ; 
  Shaklai et al., 2007  ). Therefore, the results of this study may pro-
vide a new insight into the functions of representative plasma 
membrane  –  anchored growth factors, such as the EGF family in 
transcriptional regulation. 
  Materials and methods 
  Construction of expression plasmid 
  The plasmids coding full-length HB-EGF (pME18S-HB-EGF), YFP-fused HB-
EGF (pEYFP-N1-HB-EGF), HB-EGF with the C-terminal 10 amino acids de-
leted (    10), and the uncleavable form of HB-EGF (pRCHB-EGF-L148G) are 
described in   Nanba et al. (2003)  . GFP-tagged C-terminal 10- or 15-mer 
peptide regions in HB-EGF-cyto (199  –  208 or 194  –  208, respectively) were 
constructed by inserting oligonucleotides into the pEGFP-C1. For pME18S-
HB-EGF-V5-C, the oligonucleotides corresponding to the V5-tag were in-
serted into the KpnI site of HB-EGF. For the construction of pEGFP-C1-hLAP2    
and pEGFP-C1-hLAP2    TM, human LAP2     or LAP2    TM (402  –  454) was in-
serted into the pEGFP-C1. For the construction of pEGFP-C1-HB-EGF-cyto-
hLAP2    TM, HB-EGF-cyto was inserted into the pEGFP-C1-hLAP2    TM. The 
dominant-active form of Rab5 and Rab11 plasmids were described previ-
ously (  Misaki et al., 2007  ). 
  Antibodies 
  Anti-HB-EGF-cyto rat mAb was generated based on the rat lymph node method 
originally described by Sado and colleagues (  Kishiro et al., 1995  ). A 10-wk-
old female WKY/NCrj rat (Charles River Laboratories) was immunized with 
an emulsion containing a thyroglobulin-conjugated 24-mer synthetic peptide 
corresponding to HB-EGF-cyto (obtained from Immuno-Biological Laboratories) 
and Freund  ’  s complete adjuvant. After 3 wk, cells from the lymph nodes were 
fused with mouse myeloma Sp2/0-Ag14 cells. The hybridomas were screened 
by ELISA using GST-tagged HB-EGF-cyto, and one clone was selected (desig-
nated mAbD). Rabbit anti  –  human HB-EGF antibodies (#H6) were described by 
Miyagawa et al. (  1995  ). Mouse anti-V5 mAb and goat anti-lamin B antibodies 
were obtained from Invitrogen and Santa Cruz Biotechnology, Inc., respec-
tively. Rabbit anti-GFP polyclonal antibodies were obtained from Medical   &   
Biological Laboratories. 
  Cell culture, transfection, and immunoﬂ  uorescence 
  Human ﬁ  brosarcoma HT1080 cells were grown in MEM supplemented with 
10% FCS (Hyclone) and 0.1 mM nonessential amino acids. 12-  O  -tetradec  anoyl-
phorbol-13-acetate, TPA (Sigma-Aldrich) was used at a ﬁ  nal   concentration of 
the retrograde transport pathway to the Golgi apparatus through 
recycling endosomes. Subsequently, maHB-EGF-cyto may use 
a K(X)KXX ER retrieval signal-like sequence in HB-EGF-cyto to 
reach ER. A Lap2     experiment showed that the residue 185 – 198 
is important in targeting the NE. ER-localized maHB-EGF-cyto 
can be laterally diffused between the peripheral ER, ONM, and 
  Figure 5.       A model of NE targeting.   (1) proHB-EGF is predominantly ex-
pressed on the cell surface. (2) After shedding stimuli, the equilibration 
between endocytic and recycling could be changed. (3) maHB-EGF-cyto 
possibly follows a retrograde transport pathway to the Golgi apparatus 
through recycling endosomes, and then (4) is targeted to the ER. (5) Subse-
quently ER-localized HB-EGF-cyto is diffused or actively transported to the 
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100 nM for 30 min at 37  °  C. bFGF and EGF (R  &  D systems) were used at a 
  ﬁ  nal concentration of 50 ng/ml for 30 min at 37  °  C. Transfections were per-
formed using LipofectAMINE 2000 (Invitrogen). After 16 h, the cells were 
ﬁ  xed with 4% paraformaldehyde and permeabilized with 0.4% Triton X-100 
or 0.1% Tween 20 for 5 min. The primary antibodies were detected with Cy3- 
or FITC-conjugated secondary antibodies (Jackson ImmunoResearch Laborato-
ries). Image acquisition were performed using a microscope (IX70; Olympus) 
equipped with a camera (ORCA-ER; Hamamatsu) and a 60  ×  /NA 1.4 lens. 
  To quantitate the nuclear envelope targeting, transiently HB-EGF-V5-C 
expressing cells were stained with anti-V5 mAb. The number of the cells show-
ing nuclear envelope staining and the total number of cells expressing HB-EGF-
V5-C were counted (  >  240 cells in total). Then the ratio of nuclear envelope 
accumulated cells was averaged (eight independent experiments) and shown 
as the mean   ±   SD (  n   = 8). 
  Triton X-100 extraction and digitonin permeabilization 
  Cells were extracted on ice in Transport buffer (TB: 20 mM Hepes, pH 7.3, 
110 mM potassium acetate, 5 mM sodium acetate, 2 mM magnesium ace-
tate, 1 mM EGTA, and 2 mM DTT) containing 1% Triton X-100 for 10 min. For 
digitonin permeabilization, the cells were incubated in TB containing 33   μ  g/ml 
digitonin on ice for 5 min. After extraction or permeabilization, the cells were 
washed and ﬁ  xed with 4% paraformaldehyde in TB. 
  Immunogold electron microscopy 
  Cells were ﬁ  xed with 2% paraformaldehyde/0.25% glutaraldehyde, dehy-
drated, and embedded in LR White resin. Ultra-thin sections were blocked with 
1% BSA and incubated in anti-V5 mAb. The bound antibody was detected us-
ing gold-conjugated anti  –  mouse IgG (15 nm; BBInternational). After incuba-
tion, the grids were counterstained with 2% uranyl acetate and lead citrate 
and examined with a transmission electron microscope (JEM1230; JEOL). 
  Online supplemental material 
  Fig. S1 and Fig. S2 show the quantiﬁ  cation of maHB-EGF-cyto NE targeting 
and low magniﬁ  ed immunoelectron microscopic localization of HB-EGF-cyto, 
respectively. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200710022/DC1. 
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